not tagged
cel-sci
['head and neck', '$cvm', 'cel-sci']
cel-sci s $cvm phase 3 data presented at esmo 2022: neoadjuvant #multikine achieved groundbreaking tumor response &amp; extended overall survival in locally advanced head and neck cancer #esmo22 - 
CEL-SCI's official Twitter handle. We are an immunotherapy company that focuses on unmet medical needs in oncology and infectious diseases.